Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.70 |
| ▸ | NPC1 | O15118 | 6/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.70 |
| ▸ | TSHR | P16473 | 4/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6476868 | 1.00 | RAB9A (0.70) | RAB9ANPC1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL7023628 | 0.86 | PPARG (0.64) | RAB9ANPC1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL7023625 | 0.86 | PPARG (0.64) | RAB9ANPC1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL6487303 | 0.84 | RAB9A (0.70) | RAB9ANPC1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL6476021 | 0.83 | RAB9A (0.76) | RAB9ANPC1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL7018985 | 0.81 | L3MBTL1 (0.53) | RAB9ANPC1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL7018990 | 0.81 | L3MBTL1 (0.53) | RAB9ANPC1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL6477124 | 0.80 | RAB9A (0.67) | RAB9ANPC1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL6477136 | 0.79 | RAB9A (0.63) | RAB9ANPC1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL7019578 | 0.79 | RAB9A (0.70) | RAB9ANPC1SMN1; SMN2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6919362-B2 | Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same | LES LABORATOIRES SERVIER (FR) | 2005-07-19 | — | — | US | disclosed |
| US-20030040533-A1 | Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same | LES LABORATOIRES SERVIER (FR) | 2003-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040533-A1 | Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same | CYP2F1, CYP11B2, CYP4B1 | RAB9A 3361/4885NPC1 1716/4885SMN1; SMN2 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.